Albemarle (ALB) Set to Post Quarterly Earnings on Wednesday

Albemarle (NYSE:ALB) will likely be issuing its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect Albemarle to post earnings of $2.53 per share and revenue of $1.52 billion for the quarter. Parties can check the company’s upcoming Q3 2026 earnings report for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Albemarle (NYSE:ALB) last announced its quarterly earnings data on Wednesday, August 5th. The specialty chemicals company reported $3.75 earnings per share for the quarter, topping analysts’ consensus estimates of $3.20 by $0.55. The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.61 billion. Albemarle had a return on equity of 10.96% and a net margin of 3.09%. Albemarle’s quarterly revenue was up 31.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.11 earnings per share. On average, analysts expect Albemarle to post $11.15 EPS for the current fiscal year and $11.22 EPS for the next fiscal year.

Albemarle Trading Down 0.4%

NYSE:ALB opened at $90.63 on Tuesday. The stock has a fifty day moving average price of $110.84 and a two-hundred day moving average price of $149.39. The stock has a market capitalization of $10.69 billion, a price-to-earnings ratio of 335.67, a PEG ratio of 0.58 and a beta of 1.36. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.35 and a current ratio of 2.09. Albemarle has a 1 year low of $88.01 and a 1 year high of $221.00.

Albemarle Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, December 18th will be given a dividend of $0.41 per share. This represents a $1.64 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Friday, December 18th. Albemarle’s payout ratio is presently 607.41%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Barclays initiated coverage on shares of Albemarle in a research report on Monday, October 12th. They set an “equal weight” rating and a $109.00 target price on the stock. Weiss Ratings downgraded shares of Albemarle from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, October 23rd. UBS Group reduced their price objective on shares of Albemarle from $175.00 to $150.00 and set a “buy” rating for the company in a research note on Monday, October 5th. Argus reduced their price objective on shares of Albemarle from $230.00 to $135.00 and set a “buy” rating for the company in a research note on Wednesday, October 7th. Finally, Morgan Stanley reissued a “reduce” rating and set a $161.00 price objective on shares of Albemarle in a report on Monday, August 10th. Fifteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $179.41.

Albemarle Company Profile

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.